LRRK2 and Parkinson disease: Consistently, the autopsied brain tissue of a patient from whom the iPSCs originated showed increased levels of phosphorylated tau and deposition of neurofibrillary tangles, thus establishing the LRRK2 I2020 mutation-carrying iPSCs as a useful platform for studying PD pathology [36].